Title: |
Administration of Rituximab 375 Mg/m2 on Days +1 and +8 after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Regimens for Patients with Advanced CD20+ Lymphoid Malignancies |
Source: |
Blood
[0006-4971]
Kharfan Dabaja,
Mohamed
yr:2008
|
|
|
|